US Patent Issued to Abeona Therapeutics on Oct. 28 for "Recombinant adeno-associated viral vector for gene delivery" (New York, Ohio Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,701, issued on Oct. 28, was assigned to Abeona Therapeutics Inc. (Cleveland).

"Recombinant adeno-associated viral vector for gene delivery" was invented by Timothy J. Miller (New York) and Linas Padegimas (Mayfield, Ohio).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are recombinant AAV vectors, AAV viral vectors, and capsid proteins for improved gene therapy, and methods for their manufacture and use."

The patent was filed on Dec. 4, 2019, under Application No. 17/299,434.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml...